Is Upstream Bio, Inc. (UPB) a Buy, Sell, or Hold?
NASDAQ : UPB
Upstream Bio, Inc. — Competitors
$7.09 USD
-$0.35 (-4.7%)
- Volume
- 612.07K
- Average Volume
- 593.6K
- Market Capitalization
- $385.84M
- P/E Ratio
- -2.44
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $33.68
- Year Low
- $5.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.99
UPB vs. The Competition
| Properties | UPB | AMLX | NTLA | NVAX |
|---|---|---|---|---|
| Market Cap | $385.84M | $2.63B | $1.68B | $1.31B |
| Shares Outstanding | $54.42M | $111.19M | $139.72M | $164.44M |
| P/E Ratio | -2.44 | -16.76 | -3.58 | -5.23 |
| EPS | -2.87 | -1.37 | -3.0 | -1.51 |
| Day Low | 7.0122 | 22.19 | 11.69 | 7.78 |
| Day High | 7.7 | 23.7299 | 12.14 | 8.03 |
| Year Low | 5.85 | 7.63 | 7.95 | 6.2 |
| Year High | 33.68 | 24.6 | 28.25 | 11.97 |
| Average Price 50 | 6.8608 | 17.6128 | 13.4642 | 8.6648 |
| Average Price 200 | 15.4451 | 15.09295 | 12.58688 | 8.44125 |
| Volume | 612.07K | 827.25K | 2.41M | 2.52M |
| Average Volume | - | - | - | - |